Reply To: Negative Spinal Tap-Still CIDP?

May 28, 2016 at 6:51 pm

United Healthcare’s Apheresis Policy is here:

and it includes this statement: “According to the guideline, plasmapheresis is established as effective for severe acute inflammatory demyelinating polyneuropathy (AIDP)/Guillain-Barré syndrome (GBS) and in the short
-term management of chronic inflammatory demyelinating polyneuropathy.”

I noticed when reading both of the UHC Policies that they mention ‘..state-by-state’ considerations. You might try contacting your State Insurance Commissioner for help.